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Rhabdomyosarcoma (RMS) cells were incubated with four vanadium compounds:
cations BMOV and vanadyl sulphate, and anions ortho- and metavanadate.
Growth inhibition of RMS cells in the culture was determined by two staining meth-
ods: with N-hexamethylpararosaniline (crystal violet = CV) or bromide 3-(4,5-
dimethylthiazol-2)-2,5-diphenyltetrazolium (MTT). After 48 h incubation with
10-40 µM for NaVO3 or 20-40 µM for the other three vanadium salts, the results
were statistically significantly lower (0.001 < p < 0.01) as compared to the con-
trols (without vanadium in the medium). A vanadium concentration higher than
40 µM resulted in cell destruction or death in all cells. A comparison with our pre-
viously obtained results showed the greatest sensitivity of rat hepatoma H 35-19 cells
in comparison to four human cancer cell lines (A549, DU145, HTB, RMS). Inves-
tigations of human cancer cells demonstrated that the highest resistance to ortho-
vanadate was characteristic of RMS (c.40 µM) and HTB (c. 20 µM).
Electron microscopic examination showed pleomorphic nuclei with visible amounts
of heterochromatin and large nucleoli, characteristic of RMS cells. Cells at various
stages of differentiation were observed.
Key words: human cancer cells, autocrine growth and morphology of RMS cells,
vanadyl sulphate (VOSO4), BMOV = bis(maltolato)oxovanadium, sodium ortho-
vanadate (Na3VO4), sodium metavanadate (NaVO3).
Introduction
Vanadium (atomic number 23) is a period 4, VB
group element, which appears in compounds at different
stages of oxidation (-III, -I, 0 and from +I to +V). Ac-
cording to Aureliano and Gandara 2005 [1] and Soares
et al. 2006 [2], inside various types of cells, 98% of vana-
dium appears as vanadyl ions [V(IV)], whereas vana-
date forms not only monomers but also dimers,
tetramers, pentamers and decamers that interact with
proteins. The majority of mammalian tissues contain
approximately 20 nM of vanadium; the tissue deposit
decreases in the following descending order: bone >
liver = kidney = spleen > blood > muscle > brain.
In living organisms, vanadium affects the growth, de-
velopment and differentiation of some species, and as
it has been known since 1899, it acts as an insulin-
mimetic, antidiabetic compound, while since the sec-
ond half of the 20th century, vanadium has been ac-
knowledged as a “drug”, affecting such mitogenic cell
responses as apoptosis, proliferation and neoplastic trans-
formation. Vanadium compounds are capable of op-
erating as pro- or antineoplastic agents, i.e. of induc-
ing growth or inhibiting proliferation and survival of
neoplastic cells. They act on both animal and human
cells, affecting not only neoplastic, cancer cells but also
normal cells. The results of vanadium activity have been
reported as those of anti-tumour drugs by many in-
vestigators (Ban et al. 2000 [3], Evangelou et al. 1997
[4], Molinuevo et al. 2004 [5], Scrivens et al. 2003 [6],
Zhang et al. 2001 [7], Wozniak and Blasiak 2004 [8]),
similarly as in our preliminary experiments (Holko
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et al. 2008 [9], Kordowiak et al. 2007 [10] Klein et al.
2008 [11]); however, some authors have not confirmed
this effect and suggest a contrary action of this element
(Sakai 1997 [12], Ding et al. 1999 [13], Rodriguez-
Mercado et al. 2003 [14], Shi et al. 2004 [15], Zhang
et al. 2002 [16]).
This paper presents a comparison between the in-
fluence of two inorganic salts, orthovanadate and meta-
vanadate [V(V)] and BMOV(bis (maltolato)oxovana-
dium), an organic vanadyl derivative, and vanadium
sulphate [V(IV)] on growth, survival and morpholo-
gy of the human cancer RMS cell line.
Material and methods
Reagents
Sodium orthovanadate (Na3VO4), DMEM, F12, glu-
cose, L-glutamine, trypsin, tylosine, EDTA, albumin,
penicillin, streptomycin, N-hexamethylpararosaniline
(crystal violet = CV) or bromide 3-(4,5-dime-
thylthiazol-2)-2,5-diphenyltetrazolium (MTT), glu-
taraldehyde 8% or 25% were obtained from Sigma
Chemical Company St Louis USA, vanadyl sulphate
(VOSO4) hydrate comes from Aldrich Chem. Comp Inc,
sodium metavanadate (NaVO3) comes from Fluka,
bovine serum and physiological buffered saline (PBS)
came from WSS Lublin Poland: fetal bovine serum
(FBS) was obtained from Biowest, South American Ori-
gin. For electron microscopy, Spurr epoxy resin from
Pellco Co. and formaldehyde and osmium tetroxide were
purchased from Polysciences Inc., test tubes 15 and
50 ml, Eppendorf tubes 1.5 ml, Falcon bottles of ar-
eas 25 and 75 cm, 96-well plates, 10 cm plates, ster-
ilized filters with pore size 0.22 µm were obtained from
Technoplastic Products AG, Switzerland. All other
reagent at analytical grade came from POChem Gli-
wice, Poland. Bis(maltolato)oxovanadium (BMOV) was
synthesized and characterized in Chemical Faculty UJ.
Cell culture
The human cancer rhabdomyosarcoma (RMS) cell
line was obtained from the Institute of Immunology
and Experimental Therapy, Wroclaw, Poland.
Cell proliferation assays
This investigation was conducted employing two
staining methods: N-hexamethylpararosaniline (crys-
tal violet = CV) or bromide 3-(4,5-dimethylthiazol-
2)-2,5-diphenyltetrazolium (MTT). The cells were seed-
ed on 24-well plates at a density of 12×103 per well
in 0.8 ml DMEM. After 24 h the medium was replaced
by serum-free medium and the cells were exposed to
from 0 (control without vanadium) to 60 µM of the four
vanadium salts. Within 48 h of incubation with two
inorganic salts, Na3VO4, NaVO3 [V(V) as anions], or
BMOV (an organic vanadyl derivative, i.e. bis(malto-
lato)oxovanadium), VOSO4 where [V(IV) as cations]
from 0 (control without vanadium) up to 60 µM in
serum-free medium, the mean values of IC50 of
these two tests for RMS were calculated. This paper
presents a comparison between the influence of these
four vanadium compounds on growth, survival and
morphology of the human RMS cell line. The meth-
ods of Gillies et al. 1986 [17] and Mosmann 1983 [18]
were used to determine proliferation or survival of these
cells. Each experiment was repeated at least seven times
in threefold irrespectived tests.
Statistical analysis
The results are expressed as mean ± standard er-
ror (SEM). Differences between the vanadium-treat-
ed cells and control cells were evaluated statistically us-
ing Wilcoxon’s matched pair test according to Statsoft
Statistica program (Motulsky 1996 [19] Statsoft Sta-
tistica manuals [20]). P values lower than 0.05 were
considered significant. CV and MTT results were used
to obtain a hypothetical dose-dependent curve. The sta-
tistical analysis of the obtained dose-dependent curves
was performed by MANOVA according to the Stat-
soft Statistica software.
Electron microscopic examination
After passaging, RMS cells were plated (in the
amount of 5×106/plate) on plates 10 cm in diameter
and 15 ml of DMEM with 5% FBS and 2 mM glut-
amine and 0.45% glucose, penicillin (100 units/ml) and
streptomycin (100 µg/ml) was added to each plate. Af-
ter 24 h the medium was replaced by standard defined
serum-free medium DMEM/F12 (1 : 1) with the in-
vestigated concentration of four vanadium salts (see
above). In the case of control cells, the medium con-
sisted solely of DMEM/F12 without the addition
of vanadium compounds. After 48 h at 37°C, 14 ml
of the liquid was discarded from each plate, the cells
were scraped away from the plate and placed in 1.5 ml
Eppendorf tubes with approximately 1 ml of the liq-
uid. The tubes were centrifuged in an MPW-360 cen-
trifuge at 1000 rev/min for 1 min. After discarding the
supernatant, the cells in the form of pellets were un-
derlayered with 1.5 ml of 4% glutaraldehyde at 4°C
and allowed to remain at the same temperature for ap-
proximately 60 min. Subsequently, the samples were
transferred to the Chair of Pathomorphology, Collegium
Medicum Jagiellonian University. After centrifuging,
all the samples were washed in buffer. Subsequently,
the samples were postfixed in 1% osmium tetroxide.
After dehydration in graded concentrations of ethyl al-
cohol and propylene oxide, the tissue was embedded
in Spurr medium. The samples were sectioned with an
ultramicrotome Reichert Ultracut S using a diamond
knife. Semi-thin sections were stained with methylene
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blue and ultra-thin sections with 8% uranyl acetate dis-
solved in 50% methanol and then in lead citrate ac-
cording to Venable and Coggeshal 1965 [21]. All stud-
ies were performed under the electron microscope Zeiss
EM 900 operating at 80 kV.
Results
The effect of vanadium cations (i.e. BMOV and
VOSO4) or anions (Na3VO4 and NaVO3) on autocrine
growth of rhabdomyosarcoma (RMS) human childhood
malignancies is shown in Fig 1. The figure summarizes
the mean values ± SD obtained by two different meth-
ods: CV (crystal violet) and MTT. Statistically signif-
icant values as compared with the control within
20-40 µM vanadium ion concentration were ob-
tained. Lower than 20 µM vanadium ion concentra-
tion (excluding NaVO3 which obtained the value at
10 µM) were not statistically significant; greater than
40 µM, almost all cells demonstrate destruction or death
and are not shown. Table I showed comparison of the
influence on RMS cell line growth inhibition by four
investigated vanadium compounds within the inves-
tigated concentration.
Table II presents the mean values of IC50 from the
CV and MTT study. The last result was important, be-
cause within these concentrations the cells were pre-
pared for morphological investigations. Results of the
study are shown in Figs. 2-6. Ultrastructurally, RMS
cells did not show the presence of contractile filaments,
either thick or thin. In the whole investigated group
the time of cells’ incubation was 48 h and cells were
observed under primary magnification of EM 4500×.
Control (without vanadium compounds) surviving cells
demonstrated a large number of small vacuoles and
small cytoplasmic fissures. In groups submitted to ac-
tion of both V(V) compounds there were encountered
smooth cell membranes often lacking cytoplasmic
processes or microvilli. Scarce large vacuoles at times
were filled with biological material. In cells submitted
to NaVO3 influence, large fissures in the perinuclear
zone and smaller cytoplasmic ones were observed. Cells
subjected to vanadium derivatives V(IV) had less or
more plicated cell membranes often with preserved mi-
crovilli. Large vacuoles (often digestive) appeared in cells
submitted to 45 µM BMOV action; after influence of
c. 30 µM VOSO4 the cells demonstrated fairly small
cytoplasmic vacuoles. A predominantly characteristic
observation in RMS cells was chiefly pleomorphic nu-
clei with a visible amount of heterochromatin and large
nucleoli. In all investigated groups a large number of
markedly damaged or dead cells were noted.
Discussion
Vanadium compounds in low concentrations (c. ng/g
of food) act as one of the essential microelements for
some species from algae to vertebrates, such as chick-
en or rat, but not for humans, who daily receive the
element with food and fluid intake. The mean vana-
dium concentration in blood, ranging from 0.032 to
0.095 ng/ml in the general population, reaches a much
higher level (even 1000-fold) in people exposed to high
vanadium concentration levels in the air, e.g. indus-
trial workers [22]. The molecular mechanism of in-
tracellular vanadium action is not yet fully understood.
Na3VO4 NaVO3 VOSO4 BMOV
Fig. 1. The growth inhibition of RMS cancer cell line by
four vanadium compounds determined by modified
crystal violet (CV) staining method and MTT test after
48 h of incubation in serum-free medium (DMEM/F12).
The results are presented as mean values of the two
methods. NS – non-significant (p > 0.05) in comparison
with control sample (without vanadium salts)
** 0.001< p < 0.01
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Table I. Comparison of influence on RMS cell line growth inhibition by four investigated vanadium compounds
VANADIUM % OF RMS GROWTH INHIBITION IN COMPARISON WITH CONTROL
CONCENTRATION [µM] ANIONS CATIONS
NA3VO4 NAVO3 VOSO4 BMOV
10 9.4 ±1.2 20.8 ±1.0 1.8 ±2.4 12.7 ±1.8
20 25.7 ±0.9 34.7 ±1.1 26.8 ±1.5 27.9 ±1.5
30 38.0 ±0.9 50.0 ±1.0 49.8 ±1.1 36.0 ±1.5
40 51.2 ±0.8 68.6 ±1.0 78.0 ±1.3 41.5 ±1.3
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While vanadium’s influence as an insulin-mimetic agent
acting towards normalization of metabolism of lipids
and carbohydrates is relatively well known [23], in-
tensive investigations of this microelement’s effect on
proliferation and viability of cells (including cancer cell
lines) are in progress. Vanadium derivatives as phos-
phate analogues inhibited protein tyrosine phos-
phatases and activated kinases [2, 19, 25, 26], influ-
enced gene expression, DNA repair mechanisms, cell
growth, apoptosis, and acted as pro-cancerogenic
[e.g. 24-26] or anti-cancerogenic “drugs” [15, 27, 28].
In the anti-tumour activity of vanadium, two activity
levels may be distinguished. The former consists in a cy-
toprotective effect exerted upon experimentally induced
cancers in animal models. Administration of vanadi-
um derivatives results in a decreased rate of prolifer-
ation and/or mass and number of newly developing tu-
mours. Chakraborty et al. [29-32] believe that
anti-tumour vanadium activity consists in induction
and/or stabilization of liver enzymes, as well as inhi-
bition of activity of γ-glutamyl transpeptidase and pla-
cental glutathione S-transferase. The other mechanism
involves decreasing the proliferation activity of specific
tumour cell lines. The latter stage is subject to exten-
sive studies. Having entered the cell, vanadium com-
pounds are believed to affect nuclear DNA, resulting
in formation of cross-links between DNA strands, which
hinders or even completely prevents DNA replication,
thus sending the cells on the path to apoptosis. In the
opinion of Young and Wang [28], the vanadium-se-
lenium complex exhibits multidirectional activity,
causing inhibition of S189 and H22 life cycle in S and
G2/M phase; the mechanism underlying the process
depends on Ca2+ and Mg2+ accumulation in the cell,
an increase in the amount of free radicals, a decrease
of pH in mitochondrial membranes and a decreased
potential of these membranes. Barrio et al. [33]
demonstrated antiproliferative abilities of the vanadi-
um-trehalose complex, which depended on the con-
centration employed (UMR106 cell line) and appeared
at 50-100 µM. ERK kinase stimulation in the cells was
also noted, with the activity dependent upon the con-
centration of the compound and time of exposure.
Molinuevo et al. [27] observed vanadium (IV) complex-
evoked inhibition of adhesion, migration and colony
forming in the osteosarcoma UMR cell line.
Our previous investigations showed the effect of
vanadium cation (as vanadyl sulphate) as well as an-
ion (orthovanadate) on autocrine growth and viabili-
ty of the rat hepatoma cell line H35-19 [10], similarly
as on some human carcinoma cell lines (lung, kidney
and prostate) [9, 11]. It has seemed interesting to study
Table II. IC50 values obtained by CV and MTT staining
methods for four vanadium compounds
VANADIUM COMPOUND IC50 ± SD [µM]
NaVO3 27.6 ±1.5
Na3VO4 39.4 ±0.6
VOSO4 28.2 ±0.2
BMOV 46.2 ±0.9
Fig. 2. RMS controls (C), the surviving cells as a rule
demonstrated a large number of small vacuoles and small
cytoplasmic fissures. The membrane of these cells showed
cytoplasmic processes and microvilli. In the vicinity of the
surviving cells, a high number of dead cells were seen.
Initial magnification 4500×
Fig. 3. Group treated with 40 µM Na3VO4, 48 hours of
incubation, there were encountered cells with both plicat-
ed and smooth cell membranes, often lacking cytoplasmic
processes or microvilli. The cytoplasm contained scarce
large vacuoles, at times filled with biologically foreign
material. Initial magnification 4500×
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in particular the effect of four vanadium compounds
(as two cations, VOSO4 and BMOV [V(IV)], and two
anions, Na3VO4 and NaVO3 [V(V)]) on cell growth
and viability, and to carry out a parallel investigation
of the morphology of rhabdomyosarcoma, a human can-
cer cell line. Rhabdomyosarcoma (RMS) arises main-
ly in the head and neck region, genitourinary tract and
extremities; it is the most common childhood malig-
nancy. Permanent activation of signal transduction
pathways promotes RMS growth.
Within the cell, VO2+ cation was a dominant form;
when bound to an organic ligand (BMOV), it was more
absorbable and less toxic than VOSO4 [34]. Both
[V(IV)] compounds at concentrations of approxi-
mately 10 µM resulted in a statistically significant de-
crease in proliferation rate of the investigated cells; when
the concentration increased above 20 µM, they de-
pressed respiratory activity in RMS. The half maximal
inhibitory concentration (IC50) of VOSO4 meta-
vanadate was lower by 1/3 (28 µM) as compared to
BMOV (47 µM). Orthovanadate showed an interme-
diate value (40 µM). The compounds exerted a dose
and incubation time-dependent cytotoxic effect on the
investigated cell line; the onset of proapoptotic activ-
ity was noted after 24-48 hours of incubation, while
longer incubation periods resulted in predominance of
a necrotic effect.
Electron microscopic study confirmed a relatively
high number of dead cells. Four vanadium derivatives
resulted in ultrastructural changes in RMS cells. In the
case of V(V), the cell membranes were smoothened out,
with obliteration of the cytoplasmic processes and mi-
crovilli, while the vacuoles were large; following ex-
posure to NaVO3, large fissures were seen around the
nucleus and smaller ones in the cytoplasm. As the ef-
fect of vanadium V(IV) derivatives, the cell membranes
Fig. 4. Group treated with 28 µM NaVO3, 48 hours of
incubation. In the surviving cells, the plasma membranes
were generally smooth. In addition to large vacuoles, there
were observed large fissures in the perinuclear zone and
smaller ones in the cytoplasm. Initial magnification 4500×
Fig. 5. Group treated with 28 µM VOSO4, 48 hours of
incubation. A large number of dead cells were observed.
The surviving cells showed plicated cell membrane with
preserved microvilli. The cells demonstrated fairly small
cytoplasmic vacuoles. Initial magnification 4500×
Fig. 6. Group treated with 45 µM BMOV, 48 hours of
incubation. The cells were characterized by more or less
plicated membranes. The cytoplasm showed large vac-
uoles; often these were digestive vacuoles. The cytoplasm
also demonstrated the presence of small fissures. Initial
magnification 4500×
In all the investigated groups, a large number of markedly
damaged or dead cells were noted.
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were plicated to a greater or lesser degree (similarly as
in the control cells) and the microvilli were preserved.
Large, scant and often digestive vacuoles were observed
in the cells subjected to the effect of c. 50 µM BMOV,
while following the application of c. 30 µM VOSO4,
small cytoplasmic vacuoles were noted, similarly as in
the controls. Ultrastructurally, RMS cells did not show
the presence of contractile filaments, either thick or thin.
As it follows from the literature, single thin filaments
observed at times in early-stage rhabdomyoblasts are
not present in RMS cells. Also characteristic arrange-
ments of single thick filaments surrounded by thin fil-
aments are almost never encountered in poorly differ-
entiated rhabdomyoblasts, and even less so in RMS [35].
Similarly as in our investigations, embryonal RMS
often manifests cells the morphology of which is dif-
ficult to fully diagnose. In such situations, establish-
ing the diagnosis is facilitated by clinical data, as well
as by histopathology results. In the case of cultured cells,
we are sure of both the origin and the cell line. The pres-
ence of cell dedifferentiation (especially in consecutive
passages) is a well-known phenomenon. A predomi-
nantly characteristic observation in RMS cells was chiefly
pleomorphic nuclei with a visible amount of hete-
rochromatin and large nucleoli. Similarly as in other
tumour cell lines, cells in various differentiation stages
were also noted. In the present investigations, no sig-
nificant difference was observed between particular ex-
perimental groups, while the cells originating from these
groups were markedly more damaged, most likely in
consequence of vanadium activity. In RMS cells,
practically no cytoskeleton elements were noted in ei-
ther group, control or experimental, in contrast to the
results of similar investigations carried out in human
lung cancer cells of the A549 line, where cytoskeletal
elements were seen as bundles or single intermediate
filaments or microtubules (paper being prepared for
publication).
A comparison of the present results with the results
obtained previously by our investigative team demon-
strated the highest sensitivity to vanadates and
vanadyl sulphate (IC50 up to 5 µM) of rat hepatoma
cells (H35-19) as compared to the four investigated lines
of human cells (A549 lung, DU145 prostate, HTB kid-
ney and RMS). The highest resistance to the effect of
Na3VO4 was seen in RMS cells (approx. 40 µM) and
HTB cells (20 µM), while the A549 and DU145 lines
reached IC50 already at several micromoles (5-10 µM).
Under the effect of VOSO4, both the cell lines
achieved IC50 at a concentration value that was 50%
lower as compared to RMS (15 µM versus 30 µM). The
lowest effect was exerted on RMS cells by BMOV, since
the concentration that needed to be employed reached
up to 50 µM. Analysing the resultant values, one may
state that rat hepatoma cells are more sensitive to the
effect of inorganic vanadium salts in comparison to the
four investigated lines of human cancer cells. The high-
est resistance to the effect of these compounds was seen
in the HTB and RMS cell lines.
In the investigated RMS line, a similar effect of ap-
proximately 50% growth inhibition was evoked by
metavanadate and vanadyl sulphate, with IC50 oc-
curring at < 30 µM. The weakest effect was exerted
by BMOV at c. 50 µM, while orthovanadate showed
an intermediate effect at c. 40 µM. These findings are
generally in agreement with data reported by other
authors investigating the properties of this microele-
ment. In the case of NaVO3, one should take into con-
sideration the highest toxicity of this derivative,
while BMOV showed the mildest effect both in vivo
and in vitro [36].
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